Trials / Completed
CompletedNCT01420159
Efficacy and Safety of Methoxyflurane (Penthrox) for the Treatment of Acute Pain in Minor Trauma
A Randomised, Double Blind, Multi-centre, Placebo Controlled Study to Evaluate the Efficacy and Safety of Methoxyflurane (Penthrox) for the Treatment of Acute Pain in Patients Presenting to an Emergency Department With Minor Trauma
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 300 (actual)
- Sponsor
- Medical Developments International Limited · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
This study investigates the treatment of acute pain, an unpleasant feeling caused by an injury. The overall purpose of the study is to gain more information that the pain relief medicine Penthrox(Methoxyflurane) administered using the Penthrox Inhaler(a distinctive green, whistle like object that you breathe through) is safe and works at relieving pain in patients aged 12 years and older who are admitted to a hospital Emergency Department with a minor injury (known as trauma).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Methoxyflurane | Patients will have access to two 3 mL methoxyflurane (Penthrox) Inhalers or two 5mL placebo Inhalers to be self-administered. |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2012-07-01
- Completion
- 2012-07-01
- First posted
- 2011-08-19
- Last updated
- 2012-10-31
Locations
6 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01420159. Inclusion in this directory is not an endorsement.